Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MMEDthis companyMiniMed Group, Inc.	$17.32	-10.23×	0.94×	1.09×	15.78×	-234.6%	54.2%	1.6%	-10.7%	-9.2%	1.2%	-12.4%	0.04×	-0.75×	0×	1.92×	0.0%	2	3.72	3	B
BBNXBeta Bionics, Inc.	$16.24	-16.83×	4.29×	12.32×	-17.22×	-1006.1%	55.4%	-71.5%	-73.0%	-25.5%	-23.9%	-4.6%	0.03×	0.35×	0×	8.66×	0.0%	3	9.08	2	C
DXCMDexCom, Inc.	$79.43	31.01×	9.43×	5.56×	19.41×	-50.0%	60.1%	19.6%	17.9%	30.5%	16.6%	4.2%	0.51×	0.35×	49.83×	1.88×	0.0%	8	7.49	3	B+
GCTKGlucoTrack, Inc.	$0.45	-0.18×	1.23×	0×	0.2×	41454.6%	0.0%	0.0%	0.0%	-685.6%	-520.2%	-440.6%	0.01×	0.38×	0×	1.61×	0.0%	1	-186.58	2	B-
INBSIntelligent Bio Solutions Inc.	$2.25	-0.27×	0.61×	0.8×	-0.11×	-1102.6%	48.6%	-299.1%	-294.9%	-225.6%	-176.1%	-355.8%	0.33×	0.19×	-1,174.37×	1.44×	0.0%	3	-11.23	2	C
MMMMEDVMiniMed Group, Inc.	$17.70	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	-0.23×	2.76×	3.18×	0.05×	-528.0%	52.0%	-35.8%	-36.5%	-125.5%	-100.0%	-180.2%	0.18×	0.35×	0×	1.74×	0.0%	3	-1.87	2	—